WallStreetZenWallStreetZen

NASDAQ: PRCT
Procept Biorobotics Corp Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

PRCT past revenue growth

How has PRCT's revenue growth performed historically?
Company
81.55%
Industry
9.4%
Market
16.96%
PRCT's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
PRCT's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
PRCT's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

PRCT earnings and revenue history

Current Revenue
$136.2M
Current Earnings
-$105.9M
Current Profit Margin
-77.8%

PRCT Return on Equity

Current Company
-46.6%
Current Industry
10.5%
Current Market
188%
PRCT's Return on Equity (-46.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when PRCT announces earnings.

PRCT Return on Assets

Current Company
-30.6%
Current Industry
5.3%
PRCT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

PRCT Return on Capital Employed

Current Company
-28.4%
Current Industry
8.3%
PRCT has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PRCT vs Medical Device Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
PRCT$136.19M-$98.08M-$105.90M+116.76%N/A
QDEL$3.00B$575.70M-$10.10M+41.83%N/A
TMDX$241.62M-$6.66M-$25.03M+79.36%N/A
LIVN$1.15B$38.38M$17.55M+0.83%N/A
TNDM$747.72M-$194.66M-$222.61M+32.39%N/A
View Top Medical Device Stocks

PRCT earnings dates

Next earnings date
May 1, 2024

Procept Biorobotics Earnings & Revenue FAQ

What were PRCT's earnings last quarter?

On Invalid Date, Procept Biorobotics (NASDAQ: PRCT) reported Q4 2023 earnings per share (EPS) of -$0.54, up 14.29% year over year. Total Procept Biorobotics earnings for the quarter were -$27.50 million. In the same quarter last year, Procept Biorobotics's earnings per share (EPS) was -$0.63.

If you're new to stock investing, here's how to buy Procept Biorobotics stock.

What was PRCT's earnings growth in the past year?

As of Q2 2024, Procept Biorobotics's earnings has grown year over year. Procept Biorobotics's earnings in the past year totalled -$105.90 million.

What is PRCT's earnings date?

Procept Biorobotics's earnings date is Invalid Date. Add PRCT to your watchlist to be reminded of PRCT's next earnings announcement.

What was PRCT's revenue last quarter?

On Invalid Date, Procept Biorobotics (NASDAQ: PRCT) reported Q4 2023 revenue of $43.58 million up 83.29% year over year. In the same quarter last year, Procept Biorobotics's revenue was $23.78 million.

What was PRCT's revenue growth in the past year?

As of Q2 2024, Procept Biorobotics's revenue has grown 81.55% year over year. This is 72.16 percentage points higher than the US Medical Devices industry revenue growth rate of 9.4%. Procept Biorobotics's revenue in the past year totalled $136.19 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.